SEARCH NEWS & VIEWS


A Molecular On/Off Switch for CRISPR
Scientists Discover New Class of Anti-Diabetes Compounds that Reduce Liver Glucose Production
Philip Dawson Named Dean of The Scripps Research Institute’s Graduate Program
NEWS & VIEWS HOME
PAST ISSUES
KUDOS
SCIENTIFIC CALENDAR
CA AUDITORIUM EVENTS
CONTACT

FOLLOW US
1
A Molecular On/Off Switch for CRISPR

New research from the Lander Lab reveals how viruses disable bacterial immune systems.

Scientists Discover New Class of Anti-Diabetes Compounds that Reduce Liver Glucose Production

A compound investigated by the Griffin Lab could one day be developed as either a single agent to treat Type 2 diabetes, or used in combination with current anti-diabetic drugs.

Philip Dawson Named Dean of The Scripps Research Institute’s Graduate Program

Dawson brings to his new role more than 25 years’ experience at TSRI as a student, alumnus, faculty member and associate dean.

TSRI Students Win Prestigious NSF Graduate Research Fellowships
  • These Two Molecules Appear to Drive Breast Cancer Drug Resistance
  • Mobile Technology Shakes Up Pregnancy Research
  • Potential Drug Candidates Halt Prostate and Breast Cancer Growth
  • Scripps Florida Scientists Develop New Drug Delivery Method for Cancer Therapy
  • In the Battle for Real Estate, a Disordered Protein Wins Out
  • New Enzyme-Like Tool Lets Chemists Modify Hard-to-Reach Spots on Drug Molecules
  • Scientists Take Aim at Obesity-Linked Protein
  • Researchers Find Standard Pacemakers and Defibrillators Safe for MRI Using a New Protocol
  • The Scripps Research Institute Announces New Board Members and Chairman of the Board
  • Watching the Clock: A Profile of Katja Lamia
  • Scientists Find Clue to Why Zika, But Not Its Close Relatives, Causes Birth Defects
  • Chemists Unveil Versatile New Method for Making Chiral Drug Molecules
  • Scientists Find Brain Hormone that Triggers Fat Burning
  • Deep Brain Stimulation Blocks Heroin Relapse in Rats